Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle M Maisonneuve

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|May 3, 2005
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?Olga D Taraschenko, Vishal Panchal, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|November 18, 2005
Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridineVishal Panchal, Olga D Taraschenko, Isabelle M Maisonneuve, et al.
Synapse (New York, N.Y.)|April 21, 2007
18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbensOlga D Taraschenko, Joseph M Shulan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
European Journal of Pharmacology|August 30, 2011
Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administrationStanley D Glick, Elizabeth M Sell, Sarah E McCallum, et al.
Psychopharmacology|August 30, 2008
18-methoxycoronaridine: a potential new treatment for obesity in rats?Olga D Taraschenko, Heather Y Rubbinaccio, Isabelle M Maisonneuve, et al.
Psychopharmacology|December 20, 2002
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in ratsJames R Shoblock, Eric B Sullivan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|April 22, 2006
18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in ratsStanley D Glick, Ruby L Ramirez, Jacklyn M Livi, et al.
Neuropharmacology|June 5, 2007
Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in ratsOlga D Taraschenko, Heather Y Rubbinaccio, Joseph M Shulan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19Wenjiang Zhang, Yamini Ramamoorthy, Rachel F Tyndale, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|May 3, 2005
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?Olga D Taraschenko, Vishal Panchal, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|November 18, 2005
Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridineVishal Panchal, Olga D Taraschenko, Isabelle M Maisonneuve, et al.
Synapse (New York, N.Y.)|April 21, 2007
18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbensOlga D Taraschenko, Joseph M Shulan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
European Journal of Pharmacology|August 30, 2011
Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administrationStanley D Glick, Elizabeth M Sell, Sarah E McCallum, et al.
Psychopharmacology|August 30, 2008
18-methoxycoronaridine: a potential new treatment for obesity in rats?Olga D Taraschenko, Heather Y Rubbinaccio, Isabelle M Maisonneuve, et al.
Psychopharmacology|December 20, 2002
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in ratsJames R Shoblock, Eric B Sullivan, Isabelle M Maisonneuve, et al.
European Journal of Pharmacology|April 22, 2006
18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in ratsStanley D Glick, Ruby L Ramirez, Jacklyn M Livi, et al.
Neuropharmacology|June 5, 2007
Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in ratsOlga D Taraschenko, Heather Y Rubbinaccio, Joseph M Shulan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19Wenjiang Zhang, Yamini Ramamoorthy, Rachel F Tyndale, et al.
Pageof 3